ArticleFrontiers in immunology2022

T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis.

Laura Brennan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.